INNOVATE Corp (VATE)
NYSEIndustrialsEngineering & ConstructionSnapshot 2026-11-04
$5.43-3.21%
Close 2026-11-04 · 1-day change
NYSEIndustrialsEngineering & ConstructionSnapshot 2026-11-04
QuarterlyIQ Insights · VATE
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
“At Infrastructure, DBM Global delivered a record-breaking quarter, reflecting continued strong financial performance with margin expansion and backlog growth.
Stated in 2 of 2 supplied quarters. Management reported: “Infrastructure • DBMG reported second quarter 2026 revenue of $414.0 million, an increase of 77.6%, compared to $233.1 million in the pr ior year quarter.” “• DBMG’s reported backlog and adjusted backlog, which takes into consideration awarded but not yet signed contracts, was $1.9 billion and $2.7 billion respectively, as of June 30, 2026, compared to reported and adjusted backlog of $1.7 billion and $1.8 billion, respectively, as of December 31, 2025.” Revenue was $421.600 million in 2026-Q2.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated strong grew net income 68% of the time over the next year (vs 52% for the rest of the cohort, n=6978).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
““At Infrastructure, DBM Global delivered a record-breaking quarter, reflecting continued strong financial performance with margin expansion and backlog growth.”
““DBM Global exited the quarter with strong momentum, supported by a robust pipeline and early progress building 2027 backlog, reinforcing confidence in sustained revenue and potential upside.”
“With these proceeds, we are substantially reducing our debt and strengthening INNOVATE’s balance sheet, which improves our financial flexibility as we focus on our remaining businesses.
Stated in 1 of 2 supplied quarters. Management reported: “Use of Proceeds INNOVATE intends to use all net proceeds from the Transaction to reduce its outstanding debt.” ““With these proceeds, we are substantially reducing our debt and strengthening INNOVATE’s balance sheet, which improves our financial flexibility as we focus on our remaining businesses.”
“• INNOVATE continues to pursue highly substantial asset dispositions, including a sales process for all or substantially all of DBMG's assets or equity interests, and the disposition of a majority in…”
Life Sciences • MediBeacon continued to build commercial momentum in the United States, putting the technology in the hands of the clinicians who need it most and building the evidence base that will…
Stated in 2 of 2 supplied quarters. Management reported: “MediBeacon is now actively engaged with over 100 healthcare institutions who have expressed interest in the TGFR System.” “Life Sciences • MediBeacon received the CE mark under European Medical Device Regulation for the Transdermal GFR ("TGFR TM ") Monitor and TGFR TM Reusable Sensor.”
“Life Sciences • MediBeacon continued to build commercial momentum in the United States, putting the technology in the hands of the clinicians who need it most and building the evidence base that will…”
“Life Sciences • MediBeacon received the CE mark under European Medical Device Regulation for the Transdermal GFR ("TGFR TM ") Monitor and TGFR TM Reusable Sensor.”
Commentary "INNOVATE delivered a strong second quarter and continued to execute on several important strategic priorities across the portfolio," said Avie Glazer, Chairman of INNOVATE.
Stated in 2 of 2 supplied quarters. Management reported: “The increase in Net income was primarily driven by a net increase in gross profit of $33.9 million, and an $18.7 million increase in gain on extinguishment of debt, which was partially offset by an $8.9 million increase in tax expense, a net increase in selling, general and administrative (“SG&A”) 3 expenses of $6.4 million and a $6.2 million increase in interest expense.” Net income was $10.700 million in 2026-Q2.
“Commentary "INNOVATE delivered a strong second quarter and continued to execute on several important strategic priorities across the portfolio," said Avie Glazer, Chairman of INNOVATE.”
“Financial Summary (in millions, except per share amounts) Three Months Ended March 31, 2026 2025 Increase / (Decrease) Revenue $ 364.8 $ 274.2 33.0 % Net loss attributable to common stockholders and…”
Implement a share repurchase program to return capital to shareholders.
Over the trailing year it converted -0.99x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, real (inflation-adjusted) rates, long-term interest rates, the US dollar, Fed net liquidity (low R² over the window).
29 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Industrials names rated volatile grew net income 52% of the time over the next year (vs 59% for the rest of the cohort, n=6547).
Not investment advice. As of 2026-11-04.